skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Hypertension

The Lancet (British edition), 2017-06, Vol.389 (10087), p.2365 [Peer Reviewed Journal]

2017. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)31570-2

Full text available

Citations Cited by
  • Title:
    Hypertension
  • Subjects: Angiotensin ; Antihypertensives ; Blood pressure ; Calcium ; Calcium channels ; Correlation analysis ; Drugs ; Enzyme inhibitors ; Health risk assessment ; Heart ; Historians ; Hypertension ; Myocardial infarction ; Peptidyl-dipeptidase A ; Philosophers ; Physicians
  • Is Part Of: The Lancet (British edition), 2017-06, Vol.389 (10087), p.2365
  • Description: Leading American clinicians like Harvey Cushing popularised this combination, and by the mid-20th century family doctors all over Europe and the USA could measure blood pressure accurately, using a simple, reliable piece of kit. In 1957 the first results of the US Framingham Heart Study showed a strong correlation between raised blood pressure and high mortality rates from stroke and heart attack. From 1958 the US pharmaceutical giant Merck marketed chlorothiazide as Diuril, the first widely used antihypertensive, and by the late 1960s treatments included a generation of “designer drugs”—β blockers, calcium-channel blockers, and angiotensin-converting-enzyme inhibitors.
  • Publisher: London: Elsevier Limited
  • Language: English
  • Identifier: ISSN: 0140-6736
    EISSN: 1474-547X
    DOI: 10.1016/S0140-6736(17)31570-2
  • Source: ProQuest One Psychology
    ProQuest Central

Searching Remote Databases, Please Wait